FOXO3 and breast cancer: Proteomic data were confirmed by analyzing clinical data from BC patients’ cohorts, which showed that FoxO3a expression correlates directly to G6PDH (Figure 6E) and inversely to PGLS (Figure 6F), PGD (Figure 6G), TKT (Figure 6H), MDH1 (Figure 6I) and IDH1 (Figure 6J).